局限性前列腺癌局部治疗的10年比较效果研究
该前瞻性队列纳入临床T1-T2、低中危局限性前列腺癌男性,分别接受根治性前列腺切除术(n=139)、近距离放疗(n=317)或外照射放疗(n=194),用倾向评分校正的广义估计方程分析10年患者报告结局。结果显示三组副作用模式持续至10年,近距离放疗对患者报告结局影响最小。
要点
- 根治性前列腺切除术后尿失禁与性功能障碍持续至10年。
- 近距离放疗中期出现尿控与性功能迟发恶化,10年时与手术差异仍显著。
- 外照射放疗结果类似近距离放疗,但伴肠道困扰。
核心结论
- 放疗组迟发恶化缩小了与根治性前列腺切除术的差异,但10年后患者报告结局差异仍存在。
- 近距离放疗是对患者报告结局影响最小的治疗选择,可作为局限性前列腺癌循证决策的备选方案。
研究设计与样本
- 前瞻性观察性队列研究,纳入临床T1或T2、低中危局限性前列腺癌男性。
- 根治性前列腺切除术n=139,近距离放疗n=317,外照射放疗n=194,治疗决策由患者与医生共同制定。
- 采用倾向评分校正的广义估计方程模型分析重复测量的患者报告结局变化。
主要发现
- 10年患者报告结局完成率为85.8%。
- 根治性前列腺切除术组尿失禁与性功能障碍模式持续至治疗后10年(SD分别为-1.1和-1.3)。
- 近距离放疗组中期出现尿控(SD -0.4)与性功能(SD -0.9)迟发恶化,10年时与手术差异仍显著(倾向评分校正后P < .001)。
- 外照射放疗组结果与近距离放疗相似,但伴肠道困扰(SD -0.3)。
关键数值与推荐
- 患者报告结局采用扩展前列腺癌综合指数与SF-36,治疗前及治疗后每年经电话集中访谈评估。
- 扩展前列腺癌综合指数涵盖泌尿、肠道、性和激素四个领域。
临床怎么用
- 在局限性前列腺癌治疗决策中,可将近距离放疗作为对患者报告结局影响较小的备选方案与患者讨论。
- 应向患者说明根治性前列腺切除术的尿失禁与性功能障碍可能持续至10年。
- 放疗后尿控、性功能及肠道症状的迟发恶化需长期随访管理。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Long-term comparative effectiveness research on localized prostate cancer treatments is scarce, and evidence is lacking especially for brachytherapy. The aim of this study was to assess the long-term impact of the side effects of radical prostatectomy, brachytherapy, and external radiation therapy on patients with localized prostate cancer at 10 years, using propensity score analyses. METHODS AND MATERIALS: This was a prospective observational study of a cohort of men who received a diagnosis of clinically localized prostate cancer (clinical stage T1 or T2, low and intermediate risk group) and were treated with radical prostatectomy (n = 139), brachytherapy (n = 317), or external radiation therapy (n = 194). Treatment decisions were jointly made by patients and physicians. Patient-reported outcome (PRO) evaluation included the Expanded Prostate Cancer Index Composite and Short Form-36, administered centrally by telephone interviews before and annually after treatment. The Expanded Prostate Cancer Index Composite covers urinary, bowel, sexual, and hormonal domains. To assess PRO changes over time, while accounting for correlation among repeated measures, generalized estimating equation models adjusted by propensity scores were constructed. RESULTS: The PRO completion rate at 10 years was 85.8%. Generalized estimating equation models showed that the pattern of radical prostatectomy side effects, with substantial urinary incontinence and sexual dysfunction, remained until 10 years after treatment (standard deviation [SD], -1.1 and -1.3, respectively). Brachytherapy produced late deterioration in urinary continence (SD, -0.4) and sexual function (SD, -0.9) that appeared midterm, but the differences from radical prostatectomy remained statistically significant at 10 years (P < .001 after adjusting by propensity score). External radiation therapy showed similar results to brachytherapy, but with bowel bother (SD, -0.3). CONCLUSIONS: Although late deterioration in radiation therapy groups attenuated differences from radical prostatectomy, relevant PRO differences still remained after 10 years. Our findings support that brachytherapy is the treatment option that causes the least impact on PROs; it is therefore an alternative to be considered when making evidence-based decisions on localized prostate cancer treatment.
引用
- Garin O, Suárez JF, Guedea F, et al. Comparative Effectiveness Research in Localized Prostate Cancer: A 10-Year Follow-up Cohort Study. Int J Radiat Oncol Biol Phys. 2021. PMID: 33388360. doi:10.1016/j.ijrobp.2020.12.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。